Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW 37,550
+1,750 (4.89%)
At close: Dec 19, 2025
Ildong Pharmaceutical Market Cap
Ildong Pharmaceutical has a market cap or net worth of 1.18 trillion as of December 19, 2025. Its market cap has increased by 248.33% in one year.
Market Cap
1.18T
Enterprise Value
1.28T
Revenue
575.66B
Ranking
n/a
PE Ratio
38.28
Stock Price
37,550.00
Market Cap Chart
Since August 31, 2016, Ildong Pharmaceutical's market cap has increased from 453.27B to 1.18T, an increase of 161.02%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.18T | 259.87% |
| Dec 30, 2024 | 328.76B | -34.57% |
| Dec 28, 2023 | 502.48B | -34.29% |
| Dec 29, 2022 | 764.72B | -4.31% |
| Dec 30, 2021 | 799.19B | 77.78% |
| Dec 30, 2020 | 449.54B | 18.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.96T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.69T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.10T |